Nuclear Medicine Applications in Diagnosis of Urological Tumors

Except for prostate carcinoma, there is limited data in the literature on the role of nuclear imaging methods in the management of urological cancers. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is generally the most widely used method in oncological imaging. How...

Full description

Saved in:
Bibliographic Details
Published in:Üroonkoloji bülteni 2019-06, Vol.18 (2), p.80-88
Main Authors: Araz, Mine, Ürün, Yüksel
Format: Article
Language:English
Subjects:
Antigens
Bladder
Magnetic resonance imaging
Medical prognosis
Metabolism
Metastasis
Patients
Physiology
Prostate
Prostate cancer
Tıp
Tumors
Urological cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Except for prostate carcinoma, there is limited data in the literature on the role of nuclear imaging methods in the management of urological cancers. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is generally the most widely used method in oncological imaging. However, the diagnostic power of this radiopharmaceutical in urological tumors is weakened partially due to its physiological urinary excretion. For this reason, some other 18F-labeled molecules, especially Ga-68 prostate-specific membrane antigen for prostate cancer and 18F-sodium fluoride for bone metastases, have recently gained importance. In addition, characterization of renal masses with Tc-99m methoxy isobutyl isonitrile (MIBI), a nonspecific tumor agent, and detection of bone metastases with whole-body Tc-99m methylene diphosphonate (MDP) bone scintigraphy are still used. In this review, scintigraphic methods and PET/CT imaging used in diagnosis and follow-up of urological tumors will be discussed.
ISSN:2147-2122
2147-2270
DOI:10.4274/uob.galenos.2018.1132